SAGE Open Medical Case Reports (Nov 2022)

Erythromelalgia successfully treated with low-dose gabapentin in a pediatric patient

  • Celine H Phong,
  • Suzanne W Birmingham,
  • Nathan W Rojek

DOI
https://doi.org/10.1177/2050313X221136768
Journal volume & issue
Vol. 10

Abstract

Read online

Primary erythromelalgia, while uncommon, may significantly decrease the quality of life of those affected. While many patients with erythromelalgia require systemic therapy, there is no standard of care for this condition. Herein, we report a 7-year-old girl who experienced resolution of erythromelalgia symptoms with no adverse effects after treatment with low-dose gabapentin. We also discuss the safety and efficacy of low-dose gabapentin in children for treatment of pain.